Navigation Links
FusionHealth Supports FAA’s New Policy To Detect And Treat Obstructive Sleep Apnea (OSA) Among Pilots And Controllers
Date:11/21/2013

Atlanta, GA (PRWEB) November 21, 2013

FusionHealth®, the leading provider of innovative sleep health management solutions that improve employee health and wellness by preventing chronic diseases and reducing costs directly linked to sleep disorders today commends the FAA on its new policy to detect and treat obstructive sleep apnea among pilots and controllers, as outlined here in an article by CNN on Wednesday, November 20, 2013. Significant health, safety and economic benefits are associated with sleep apnea treatment and made possible by technology-enabled sleep health management solutions, such as the Sleep4YourHealth program available anywhere in the U.S. via the FusionHealth i.AIM® Platform.

FusionHealth’s Sleep4YourHealth end-to-end sleep health management solution for employers is designed to accomplish precisely what the FAA is looking to do. The Sleep4YourHealth solution allows the deployment of comprehensive sleep health management programs to business associates - such as pilots and air traffic controllers - and seamlessly delivers superior levels of engagement and adherence using various corrective sleep therapies. In addition, FusionHealth’s solutions are cost effective and drive a measurable return on investment to the bottom line.

The FAA announced it would begin its program by testing pilots with a body mass index (BMI) of more than 40 and neck size larger than 17 inches, to determine if they suffer from OSA. Clinical data suggests that there is a strong correlation between a high BMI and Obstructive Sleep Apnea. Eventually, the FAA plans to lower the BMI threshold to 30, and will include air traffic controllers in the detection and treatment program.

“Not only are obese people more prone to suffer from OSA, data now suggests that the presence of OSA contributes to obesity itself,” stated Dr. Jeffrey Durmer, Co-Founder and Chief Medical Officer of Fusion Health, and Sleep Medicine Counsel to the FAA. “We’ve been helping companies in the transportation industry successfully deal with this critically important health issue for many years. From our clinical experience as well as years of research, we know that the key to success for any OSA program is adherence to sleep treatments. Our innovative technology-enabled care management approach has been very successful in attaining unparalleled levels of adherence to long-term effective treatments.”

About FusionHealth
FusionHealth®, headquartered in Atlanta, GA, delivers technology-enabled integrated sleep health management solutions for companies seeking to improve employee health and reduce health-related costs. The company’s SaaS-based delivery model provides its client companies with access to its global technology platform enabling them to integrate sleep health management with personal wellness and employee engagement in a way that changes lives and improves their bottom line performance. For more information, visit http://www.fusionhealth.com.

Company Contact
Craig Reamsnyder                
EVP Business Development, FusionHealth
888-505-0280 - cr(at)fusionhealth(dot)com    
P.R. Contact
Randy Salisbury
Marketing & Communications, FusionHealth
404-229-4242 - rsalisbury(at)fusionhealth(dot)com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11357632.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. FusionHealth to Present at The North American Transportation Employee Relations Conference (NATERA)
2. FusionHealth Unveils New Technology to Expand its Sleep4YourHealth® Sleep Health Management Solution
3. FusionHealth Receives HealthCare Consumerism Superstar Industry Innovator Award
4. Study Supports Value of Sigmoidoscopy, an Alternative to Colonoscopy
5. Study supports urate protection against Parkinsons disease, hints at novel mechanism
6. Dietary fiber alters gut bacteria, supports gastrointestinal health
7. Narconon Louisiana Supports United Nations International Day Against Drug Abuse and Illicit Trafficking
8. NIDA supports development of combined anti-heroin and HIV vaccine
9. Little evidence supports autism treatment options in adolescents
10. $1.8 million grant supports investigation of psoriasis link to cardiovascular disease
11. John Templeton Foundation grant supports Princeton neuroscientists to study cognitive control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... , ... “Tomorrow Trump Goes To Washington”: a brief but engaging illustration ... to America. “Tomorrow Trump Goes To Washington” is the creation of published author, Nancy ... country. , Nancy attributes her patriotic nature to her WWII veteran father. She ...
(Date:12/7/2016)... ... 2016 , ... Dr. Greg Leyer, the Chief Scientific Officer ... DC workshop on November 2nd. The conference was an opportunity for both probiotic ... regulations. , Dr. Leyer spoke about two main topics at the IPA ...
(Date:12/6/2016)... ... December 06, 2016 , ... Men with gum disease ... of serious health problems, such as cardiovascular illness, according to research cited in ... Hills Periodontics & Dental Implant Center notes that the correlation between periodontal disease ...
(Date:12/6/2016)... TX (PRWEB) , ... December ... ... in predictive and prescriptive health insights for population health management, announces today ... provider. VitreosHealth will leverage CitiusTech’s cloud-hosted clinical rules engine that offers advanced ...
(Date:12/6/2016)... ON (PRWEB) , ... December 06, 2016 , ... CarriersEdge, ... today announced a new suite of Driver Wellness courses. Offered in three modules, the ... a starting point so fleets can educate drivers about how to stay healthy on ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016 The pen needles market ... from USD 1.65 billion in 2016, growing at a ... to 2021. Over the years, the pen needles ... cater to the growing demand for safety injections in ... development of safety pen needles with an aim to ...
(Date:12/6/2016)... , Dec. 6, 2016   AlloSource ... cartilage, cellular, bone, skin and soft-tissue allografts for ... , Business Process Manager, for being named to ... Baldrige National Quality Award by the Commerce Department,s ... the organization,s commitment to process excellence. The Baldrige ...
(Date:12/6/2016)... 6, 2016  Nearly 30 million people in ... epidemic of diabetes. 1 However, nearly 40% of ... levels (hyperglycemia) and significant glucose variability. 2 These patients ... cardiovascular events. If left untreated, hyperglycemia can lead to ... or blindness. 3 As part of ...
Breaking Medicine Technology: